Boston Scientific (NYSE: BSX) announced on social media that it completed its previously announced acquisition of Bolt ...

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

Boston Scientific plans to break ground soon on a major expansion in Maple Grove, a project that’s up for $1.66 million in ...

Shares of Boston Scientific Corp. BSX advanced 1.53% to $100.88 Monday, on what proved to be an all-around favorable trading ...

Good morning Maple Grove! Your connection to what's happening around town is here. Take a sip of coffee and read on. ☕️️ In ...

Boston Scientific received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA's 510(k) ...

This was the stock's third consecutive day of losses.

Boston Scientific Co. (NYSE:BSX – Get Free Report) has been assigned an average recommendation of “Buy” from the twenty-three research firms that are presently covering the stock, MarketBeat.com ...

Boston Scientific led a $175 million investment in heart disease device developer 4C Medical Technologies. The investment, which 4C Medical disclosed Wednesday, will support an ongoing pivotal ...

Bullish option flow detected in Boston Scientific (BSX) with 2,458 calls trading, 1.0x expected, and implied vol increasing almost 2 points to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Boston Scientific (NYSE: BSX) is buying into the business of acquisitions. The Marlborough medical device firm has announced its second acquisition thus far in 2025. Boston Scientific Corp. has ...